FDA · Drugs · Wednesday, July 8

Levothyroxine Sodium Tablets recall

ACCORD HEALTHCARE, INC. recalled Levothyroxine Sodium Tablets on July 8, 2026 because of subpotent drug. It was sold nationwide.

Why it was recalled

Subpotent Drug

What's recalled

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.

Quantity: 6432 bottles

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice

Details

Company: ACCORD HEALTHCARE, INC., Raleigh, NC
Date: Wednesday, July 8
Severity: Class II
the product could cause temporary or reversible health problems.
Where sold: Nationwide
US Nationwide.
Status: Ongoing
Recall number: D-0656-2026
Source: U.S. Food and Drug Administration

More drugs recalls

TRP The Relief Products* Gentle Eyes Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Clear Eyes Redness Relief
Wed, Sep 30 · Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Lubricant Eye Drops-Cameron Pharmaceuticals
Wed, Sep 30 · Sterling Pharmaceutical Services LLC Reliable -1 Laboratories
Wed, Sep 30 · Sterling Pharmaceutical Services LLC